Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Impact of COVID-19 infection in blood cancer patients

Impact of COVID-19 infection in blood cancer patients

Study paves way for faster, more accurate therapies for hard-to-treat leukaemia patients

Study paves way for faster, more accurate therapies for hard-to-treat leukaemia patients

Phase III results show rituximab excels against paediatric Burkitt lymphoma

Phase III results show rituximab excels against paediatric Burkitt lymphoma

Discovery in human acute myeloid leukaemia could provide novel pathway to new treatments

Discovery in human acute myeloid leukaemia could provide novel pathway to new treatments

ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML

ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML

ASCO 2020: Early data show cancer progression associated with increased risk of death in patients with COVID-19

ASCO 2020: Early data show cancer progression associated with increased risk of death in patients with COVID-19

Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma

Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma

Clinical trial announced to study impact of severe COVID-19 infection on patients who receive stem cell transplants for blood cancers and disorders

Clinical trial announced to study impact of severe COVID-19 infection on patients who receive stem cell...

Researchers ID target for colorectal cancer immunotherapy

Researchers ID target for colorectal cancer immunotherapy

More selective elimination of leukaemia stem cells and blood stem cells

More selective elimination of leukaemia stem cells and blood stem cells

More from ecancer